Objective
State of the art "population"' pharmacokinetic analysis is used to explain and predict the interindividual variability of three costly and chronically administered immunosuppressants, antineoplasic and antiepileptic drugs.
Topic(s)
Data not availableCall for proposal
Data not availableFunding Scheme
RGI - Research grants (individual fellowships)Coordinator
15771 ATHENS
Greece